RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
87 hedge funds and large institutions have $572M invested in Rubius Therapeutics, Inc in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 33 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
21% less repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 33
Holders
87
Holding in Top 10
3
Calls
$2.44M
Puts
$402K
Top Buyers
| 1 | +$8.73M | |
| 2 | +$3.31M | |
| 3 | +$2.12M | |
| 4 |
D.E. Shaw & Co
New York
|
+$939K |
| 5 |
HHAM
HITE Hedge Asset Management
Braintree,
Massachusetts
|
+$674K |
Top Sellers
| 1 | -$560K | |
| 2 | -$309K | |
| 3 | -$297K | |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$286K |
| 5 |
Squarepoint
New York
|
-$245K |